(Q38436685)

English

Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease

scientific article published on 06 February 2014

Statements

Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease (English)
Liam M McCormick
Anna C Kydd
Philip A Read
Liam S Ring
Simon J Bond
Stephen P Hoole
David P Dutka
6 February 2014
274-281

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit